I don't pretend to be an expert in how long a patent life should be extended. I guess what we are saying is that the access piece is most important to people with Alzheimer's disease, and we're actually just saying that the playing field should be levelled with what is already occurring in the EU and the United States.
On November 15th, 2011. See this statement in context.